Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

HELP — Cybin D/B/A Helus Pharma Dilution Risk Tracker

Track HELP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HELP — Get alerts when the score changes →

As of August 28, 2026, Cybin D/B/A Helus Pharma (HELP) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Cybin D/B/A Helus Pharma has a market capitalization of $227.02M, 21.60M shares outstanding, 82 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for HELP.
🔔 Track HELP — Get forecast alerts →

Market Data

Market Cap$227.02M
Shares Outstanding21.60M
FloatN/A
Cash$149.6K
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↓ 13.9% shares (2026Q1 vs prior)
82 institutional holders · 26.81M shares
#1 Venrock Adviser, LLC 3.85M shares
#2 ORBIMED ADVISORS LLC 3.83M shares
#3 MORGAN STANLEY 2.55M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.15M
Days to Cover1.7
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track HELP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HELP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note